As of 2024-07-27, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (6,013.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -1957133.4%.
The range of the Relative Valuation is (5,956.69) - (6,162.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 31.2x - 41.3x | 31.8x |
Forward P/E multiples | 30.5x - 32.3x | 31.2x |
Fair Price | (5,956.69) - (6,162.88) | (6,013.96) |
Upside | -1938495.0% - -2005593.3% | -1957133.4% |
Date | P/E |
2024-07-25 | -0.00 |
2024-07-24 | -0.00 |
2024-07-23 | -0.00 |
2024-07-22 | -0.00 |
2024-07-19 | -0.00 |
2024-07-18 | -0.00 |
2024-07-17 | -0.00 |
2024-07-16 | -0.00 |
2024-07-15 | -0.00 |
2024-07-12 | -0.00 |
2024-07-11 | -0.00 |
2024-07-10 | -0.00 |
2024-07-09 | -0.00 |
2024-07-08 | -0.00 |
2024-07-05 | -0.00 |
2024-07-03 | -0.00 |
2024-07-02 | -0.00 |
2024-07-01 | -0.00 |
2024-06-28 | -0.00 |
2024-06-27 | -0.00 |
2024-06-26 | -0.00 |
2024-06-25 | -0.00 |
2024-06-24 | -0.00 |
2024-06-21 | -0.00 |
2024-06-20 | -0.00 |
2024-06-18 | -0.00 |
2024-06-17 | -0.00 |
2024-06-14 | -0.00 |
2024-06-13 | -0.00 |
2024-06-12 | -0.00 |
2024-06-11 | -0.00 |
2024-06-10 | -0.00 |
2024-06-07 | -0.00 |
2024-06-06 | -0.00 |
2024-06-05 | -0.00 |
2024-06-04 | -0.00 |
2024-06-03 | -0.00 |
2024-05-31 | -0.00 |
2024-05-30 | -0.00 |
2024-05-29 | -0.00 |
2024-05-28 | -0.00 |
2024-05-24 | -0.00 |
2024-05-23 | -0.00 |
2024-05-22 | -0.00 |
2024-05-21 | -0.00 |
2024-05-20 | -0.00 |
2024-05-17 | -0.00 |
2024-05-16 | -0.00 |
2024-05-15 | -0.00 |
2024-05-14 | -0.00 |